Company & Sponsor Intelligence
Anhui Medical University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting0
Completed3
Countries1
Therapeutic footprint
alzheimersdepressionout_of_scopeparkinsonsschizophrenia
Indexed studies
NCT06109480Effect of HD-tDCS Assisted ECT for Depression Disorder
depression · ChinaNA
depression · ChinaNA
NCT05625386Dual-target, High-dose TMS for PD Patients With FOG
out_of_scope · ChinaNA
out_of_scope · ChinaNA
NCT04425278tDCS Intervention on Motivational Anhedonia of Major Depressive Disorder
depression · ChinaNA
depression · ChinaNA
NCT05678725Transcranial Direct/ Alternating Current Stimulation for Parkinson's Disease Treatment
parkinsons · ChinaNA
parkinsons · ChinaNA
NCT06732817Personalized Dual-target RTMS for Patients with Refractory Schizophrenia
schizophrenia · ChinaNA
schizophrenia · ChinaNA
NCT04754152Long-term Effect of θ Burst Magnetic Stimulation on Clinical Symptoms of Alzheimer Disease
alzheimers · ChinaNA
alzheimers · ChinaNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →